InhaleRx Ltd (ASX: IRX) (‘InhaleRx’ ‘IRX’ or ‘the Company’), an Australian healthcare company developing unique drug-device products to address unmet...
Read moreHavilah Resources Limited (Havilah or the Company) (ASX: HAV) is pleased to report that it has entered into binding agreements...
Read moreUnico Silver Limited (“USL” or the “Company”) refers to the announcement on 20 August 2024 regarding the proposed acquisition of...
Read moreChip stocks faced losses early this week, sparking volatility in the tech sector. Meanwhile, Bitcoin was on the rise after...
Read moreLode Gold Resources Inc. (TSXV: LOD) (OTCQB: SBMIF) (‘Lode Gold’ or the ‘Company’) is pleased to announce that a Heliborne...
Read moreGeneral Motors (GM) (NYSE:GM) is strengthening its connection toLithium Americas (TSX:LAC,NYSE:LAC) via a joint venture centered on advancing the Thacker...
Read moreBold Ventures Inc. (BOL: TSX.V) (the ‘Company’ or ‘Bold’) is pleased to announce that further to its press releases dated...
Read moreGlobal chipmaker Taiwan Semiconductor Manufacturing Company (TSMC) (NYSE:TSM,TPE:2330) reported strong Q3 results despite ongoing controversies over alleged violations of US...
Read moreIn recent years, the global oil market has been impacted significantly by COVID-19 disruptions, price wars between oil-producing nations, Russia’s...
Read moreThe S&P/TSX Venture Composite Index (INDEXTSI:JX) was up 2.68 percent on the week to close at 621.67 on Friday (October...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved